Cancer Screening and Prevention in Lesbian, Gay, Bisexual, and Transgendered Community and Asian Lesbian, Gay, Bisexual, and Transgendered Members

Polek, Carolee; Hardie, Thomas

doi:10.4103/apjon.apjon_46_19

Cited by 16 publications

(15 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This screening could be essential in the transgender community because people with HCV are asymptomatic and could pass on the disease to those around them and their sexual partners. By identifying these people, higher prevalence and transmission of this infection could be prevented with other transgender people or their other sexual partners, including lesbian, gay, bisexual, and other sexual minorities [ 20 , 40 – 42 ]. This study showed that the prevalence of HCV in Asian and American transgender people was higher than that of Europeans.…”

Section: Discussionmentioning

confidence: 99%

The prevalence of hepatitis C and hepatitis B in lesbian, gay, bisexual and transgender populations: a systematic review and meta-analysis

et al. 2022

View full text Add to dashboard Cite

Objectives This study aimed to systematically review the literature on the prevalence of hepatitis C virus (HCV) and hepatitis B virus (HBV) infections in transgender and LGBT people and determine their pooled estimates worldwide. Methods Databases (PubMed, Scopus, Web of Science, Embase, Ovid, Cochrane, PsycInfo) were searched from April 2000 to July 2021. The analyses were executed using the random-effects model in Stata 16. Results Ten studies, including eight studies on four transgender people and two studies on 2150 LGBTs, were included. The pooled prevalence of HCV and HBV in all transgender populations globally were 9% (95% CI 3–15%) and 11% (95% CI 2–20%), respectively. The corresponding prevalence in male-to-female transgender people were estimated as 5% (95% CI 1–9%) and 6% (95% CI 3–10%), respectively. These estimates in American transgenders were 10% (95% CI 5–25%) and 16% (95% CI 8–23%), respectively. Conclusion This study was identified the overall prevalence of HBV and HCV infections in transgender people, which were higher than those in the general population.

show abstract

Section: Discussionmentioning

confidence: 99%

The prevalence of hepatitis C and hepatitis B in lesbian, gay, bisexual and transgender populations: a systematic review and meta-analysis

et al. 2022

View full text Add to dashboard Cite

show abstract

“…This follows recognition of the vulnerability and unique concerns of this underserved patient population, who have a high rate of unmet needs ( 3 – 6 ). LGBTQI individuals are at higher risk of cancer compared with the general population ( 4 , 5 , 7 ), but are less likely to engage in cancer screening or have a regular healthcare provider ( 8 – 10 ). More specifically, LGBTQI patients report high levels of dissatisfaction with cancer healthcare ( 3 , 11 ), barriers to accessing cancer services ( 3 ), and difficulties in communication with HCPs ( 4 , 12 ).…”

Section: Introductionmentioning

confidence: 99%

LGBTQI Inclusive Cancer Care: A Discourse Analytic Study of Health Care Professional, Patient and Carer Perspectives

et al. 2022

View full text Add to dashboard Cite

BackgroundAwareness of the specific needs of LGBTQI cancer patients has led to calls for inclusivity, cultural competence, cultural safety and cultural humility in cancer care. Examination of oncology healthcare professionals’ (HCP) perspectives is central to identifying barriers and facilitators to inclusive LGBTQI cancer care.Study AimThis study examined oncology HCPs perspectives in relation to LGBTQI cancer care, and the implications of HCP perspectives and practices for LGBTQI patients and their caregivers.Method357 oncology HCPs in nursing (40%), medical (24%), allied health (19%) and leadership (11%) positions took part in a survey; 48 HCPs completed an interview. 430 LGBTQI patients, representing a range of tumor types, sexual and gender identities, age and intersex status, and 132 carers completed a survey, and 104 LGBTQI patients and 31 carers undertook an interview. Data were analysed using thematic discourse analysis.ResultsThree HCP subject positions – ways of thinking and behaving in relation to the self and LGBTQI patients – were identified:’Inclusive and reflective’ practitioners characterized LGBTQI patients as potentially vulnerable and offered inclusive care, drawing on an affirmative construction of LGBTQI health. This resulted in LGBTQI patients and their carers feeling safe and respected, willing to disclose sexual orientation and gender identity (SOGI) status, and satisfied with cancer care. ‘Egalitarian practitioners’ drew on discourses of ethical responsibility, positioning themselves as treating all patients the same, not seeing the relevance of SOGI information. This was associated with absence of LGBTQI-specific information, patient and carer anxiety about disclosure of SOGI, feelings of invisibility, and dissatisfaction with healthcare. ‘Anti-inclusive’ practitioners’ expressed open hostility and prejudice towards LGBTQI patients, reflecting a cultural discourse of homophobia and transphobia. This was associated with patient and carer distress, feelings of negative judgement, and exclusion of same-gender partners.ConclusionDerogatory views and descriptions of LGBTQI patients, and cis-normative practices need to be challenged, to ensure that HCPs offer inclusive and affirmative care. Building HCP’s communicative competence to work with LGBTQI patients needs to become an essential part of basic training and ongoing professional development. Visible indicators of LGBTQI inclusivity are essential, alongside targeted resources and information for LGBTQI people.

show abstract

“…This screening could be essential in the transgender community because people with HCV are asymptomatic and could pass on the disease to those around them and their sexual partners. By identifying these people, higher prevalence and transmission of this infection could be prevented with other transgender people or their other sexual partners include lesbian, gay, bisexual, and other sexual minorities (18,(38)(39)(40). This study showed that the prevalence of HCV in Asian and American transgender people was higher than that of Europeans.…”

Section: Discussionmentioning

confidence: 67%

The Prevalence of Hepatitis C and Hepatitis B in Lesbian, Gay, Bisexual and Transgender Populations: A Systematic Review and Meta-Analysis

Moradi

soheili

Rashti

et al. 2021

Preprint

View full text Add to dashboard Cite

Objectives: This study aimed to systematically review the literature on the prevalence of Hepatitis C virus (HCV) and Hepatitis B virus (HBV) infections in transgender and LGBT people and determine their pooled estimates worldwide.Methods: Databases (PubMed, Scopus, Web of Science, Embase, Ovid, Cochrane, PsycInfo) were searched from April 2000 to July 2021. The pooled, subgroup, and cumulative analyses were executed using the random-effects model in Stata 16. Results: Ten studies, including eight studies on Four transgender people and two studies on 2150 LGBTs, were included. The pooled prevalence of HCV and HBV in all transgender populations globally were 9% (95%CI: 3- 15%) and 11% (95%CI: 2- 20%), respectively. The corresponding prevalence in male-to-female transgender people were estimated as 5% (95%CI: 1- 9%) and 6% (95%CI: 3- 10%), respectively. These estimates in American transgenders were 10% (95%CI: 5- 25%) and 16% (95%CI: 8- 23%), respectively. Conclusion: This study was identified the overall prevalence of HBV and HCV infections in transgender people, which were higher than those in the general population. Thus, this group of sexual minorities was at higher risk for HBV and HCV infections, and it was necessary to develop, design, and implement a protocol for providing services related to HBV and HCV infections, such as a hepatitis B vaccination program and treatment of hepatitis C along with screening and designing appropriate interventions in transgender people.

show abstract

Cancer Screening and Prevention in Lesbian, Gay, Bisexual, and Transgendered Community and Asian Lesbian, Gay, Bisexual, and Transgendered Members

Cited by 16 publications

References 28 publications

The prevalence of hepatitis C and hepatitis B in lesbian, gay, bisexual and transgender populations: a systematic review and meta-analysis

The prevalence of hepatitis C and hepatitis B in lesbian, gay, bisexual and transgender populations: a systematic review and meta-analysis

LGBTQI Inclusive Cancer Care: A Discourse Analytic Study of Health Care Professional, Patient and Carer Perspectives

The Prevalence of Hepatitis C and Hepatitis B in Lesbian, Gay, Bisexual and Transgender Populations: A Systematic Review and Meta-Analysis

Contact Info

Product

Resources

About